Aug 2, 2024, 01:25
Updated Clinical Practice Guidelines in Oncology for Imetelstat – MDS Foundation
MDS Foundation shared on X:
“On July 26th, 2024, the National Comprehensive Cancer Network updated its Clinical Practice Guidelines in Oncology for MDS. RYTELO™ (imetelstat) is now recommended as a Category 1 and 2A treatment for symptomatic anemia in patients with lower-risk MDS.”
Source : MDS Foundation/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jan 11, 2025, 09:26
Jan 11, 2025, 09:17
Jan 11, 2025, 09:00
Jan 11, 2025, 08:55
Jan 11, 2025, 08:44
Jan 11, 2025, 08:44
Jan 11, 2025, 08:36